Ferritin and ferritin isoforms II: Protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes

Archives of Physiology and Biochemistry

Volumn 113, Issue 2, 2007, Pages 55-64

  Koorts, A M ^a,b   Viljoen, M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Department of Physiology ^*  (South Africa)

Author keywords

Ferritin; H subunit; Inflammation; Isoferritins; L subunit; Oxygen radicals; Uncontrolled cellular proliferation

Indexed keywords

AUTACOID; FERRITIN; ISOPROTEIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; HUMAN; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; FERRITINS; HUMANS; INFLAMMATION MEDIATORS; OXIDATIVE STRESS; PROTEIN ISOFORMS;

EID: 34250174826     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450701422575     Document Type: Article

References (107)

1. Alvarez-Hernández X, Feistein MV, Brock JH. 1986. The relationship between iron release, ferritin synthesis and intracellular iron distribution in mouse peritoneal macrophages. Evidence for a reduced level of metabolically available iron in elicited macrophages. Biochim Biophys Acta 886:214-22.
2. Alvarez-Hernández X, Licéaga J, McKay IC, Brock JH. 1989. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61(3):319-22.
3. Annuk M, Zilmer M, Fellstrom B. 2003. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease. Kidney Int Suppl 84:550-3.
4. Applegate LA, Scaletta C, Panizzon R, Frenk E. 1998. Evidence that ferritin is UV inducible in human skin: Part of a putative defense mechanism. J Invest Dermatol 111(1):159-63.
5. Arosio P, Levi S, Santambrogio P, Cozzi A, Luzzago A, Cesarini G, Albertini A. 1991. Structural and functional studies of human ferritin H and L chains. Curr Stud Hematol Blood Transf 58:127-31.
6. Arosio P, Levi S. 2002. Ferritin, iron homeostasis, and oxidative damage. Free Rad Biol Med 33(4);457-63.
7. Aulbert E, Schmidt CG. 1985. Ferritin - a tumor marker in myeloid leukaemia. Cancer Detect Prev 8(1/2):297-302.
8. Aulbert E, Steffens O. 1990. Serum ferritin - a tumor marker in malignant lymphomas? Onkologie 13(2):102-8.
9. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G. 2003. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 18(Suppl 5):v8-12.
10. Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. 2004. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci 1012:224-36.
11. Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, et al. 2003. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17(12):1724-6.
12. Bevilacqua MA, Costanzo F, Buonaguro L, Cimino F. 1988. Ferritin H and L mRNAs in human neoplastic tissues. Ital J Biochem 37(1): 1-7.
13. Bevilacqua MA, Faniello MC, D'Agostino P. 1995. Transcriptional activation of the H-ferritin gene in differentiated Caco-2 cells parallels a change in the activity of the nuclear factor Bbf. Biochem J 311 (Pt 3):769-73.
14. Biemond P, Swaak AJG, Van Eijk HG, Koster JF. 1988. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Rad Biol Med 4:185-98.
15. Blake DR, Lunec J, Ahern M, Ring EF, Bradfield J, Gutteridge JM. 1985. Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis 44(3): 183-8.
16. Bomford A, Conlon-Hollingshead C, Munro HN. 1981. Adaptive responses of rat tissue isoferritins to iron administration; changes in subunit synthesis, isoferritin abundance, and capacity for iron storage. J Biol Chem 256(2):948-55.
17. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW. 1985. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 260(21): 11755-61.
18. Cai CZ, Birk DE, Linsenmayer TF. 1998. Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell 9(5):1037-51.
19. Chi SI, Wang CK, Chen JJ, Chau LY, Lin TN. 2000. Differential regulation of H- and L-ferritin messenger RNA subunits, ferritin protein and iron following focal cerebral ischemiareperfusion. Neurosci 100(3):475-84.
20. Chiancone E, Stefanini S. 1984. Heterogeneity of ferritin. I. Structural and functional aspects. In: Albertini A, Arosio P, Chiancone E, Drysdale J, editors, Ferritins and isoferritins as biochemical markers. Amsterdam: Elsevier Science Publishers, pp 23-32.
21. Closa D, Folch-Puy E. 2004. Oxygen free radicals and the systemic inflammatory response. IUBMB Life 56(4):185-91.
22. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P. 1995. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 65:717-24.
23. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. 1991. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953-75.
24. Dexter DT, Jenner P, Schapira AHV, Marsden CD. 1992. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting basal ganglia. Ann Neurol 32:S94-100.
25. Di Virgilio F. 2004. New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. Curr Pharm Design 10(14):1647-52.
26. Epsztein S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C, Cabantchik ZI. 1999. H-ferritin subunit over-expression in erymroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94(1):3593-603.
27. Fahmy M, Young SP. 1993. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: Changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 296:175-81.
28. Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, Hirsch EC. 2002. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem 83(2):320-30.
29. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A. 2000. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem 275(47): 36708-12.
30. Fillet G, Cook JD, Finch CA. 1974. Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport. J Clin Invest 53:1527-33.
31. Fillet G, Beguin Y, Baldelli L. 1989. Model of reticuloendothelial iron metabolism in humans: Abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 74(2):844-51.
32. Finch CA, Huebers HA, Cazzola M, Bergamaschi G, Bellotti V. 1984. Storage iron. In: Albertini A, Arosio P, Chiancone E, Drysdale J, editors. Ferritins and isoferritins as biochemical markers. Amsterdam: Elsevier Science Publishers, pp 3-21.
33. Fuchs D, Zangerle R, Artner-Dworzak E, Weiss G, Fritsch P, Tilz GP, Dierich MP, Wachter H. 1993. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur J Haematol 50:90-4.
34. Gerlach M, Ben-shachar D, Riederer P, Youdim MB. 1994. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63(3):793-807.
35. Giordano N, Vaccai D, Cintorino M, Minacci C, Magaro L, Battisti E, Marcucci P, Cecconami L, Marcolongo R. 1991. Histopathological study of iron deposit distribution in the rheumatoid synovium. Clin Exp Rheumatol 9(5):463-7.
36. Gonzales S, Erario MA, Tomaro ML. 2002. Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev Neurosci 24:161-8.
37. Goralska M, Holley BL, McGahan MC. 2001. Overexpression of H- and L-ferritin subunits in lens epithelial cells: Fe metabolism and cellular response to UVB irradiation. Invest Ophthalmol Vis Sci 42(8):1721-7.
38. Goralska M, Holley BL, McGahan MC. 2003. Identification of a mechanism by which lens epithelial cells limit accumulation of overexpressed ferritin H-chain. JBiol Chem 278(44):42920-26.
39. Halliday JW, Powell LW. 1979. Serum ferritin and isoferritins in clinical medicine. Progr Hematol 11:229-66.
40. Hanada T, Yoshimura A. 2002. Regulation of cytokine signalling and inflammation. Cytokine Growth Factor Rev 13(4/5):413-21.
41. Higgy NA, Salicioni AM, Russo IH, Zhang PL, Russo J. 1997. Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells. Mol Carcinog 20(4)1332-9.
42. Hirose W, Ikematsu K, Tsuda R. 2003. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Legal Med 5:8360-6.
43. Hurairah H, Ferro A. 2004. The role of the endothelium in the control of vascular function. Int J Clin Pract 58(2):173-83.
44. Ikeda H, Koga Y, Oda T, Kuwano K, Nakayama H, Ueno T, Toshima H, Michael LH, Entman ML. 1994. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. J Am Coll Cardiol 24(7): 1749-56.
45. Jones BM, Worwood M, Jacobs A. 1980. Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin. Clin Chim Acta 106:203-14.
46. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, Vercellotti GM. 1995. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147(3):782-9.
47. Jurado RL. 1997. Iron, infections, and anemia of inflammation. Clin Infect Dis 25:888-95.
48. Kakhlon O, Gruenbaum Y, Cabantchik ZI. 2001. Repression of the heavy ferritin chain increases the labile iron pool of human K562 cells. Biochem J 356(Pt 2):311-16.
49. Kakhlon O, Gruenbaum Y, Cabantchik ZI. 2001. Repression of ferritin expression increase the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 97(9):2853-71.
50. Kakhlon O, Gruenbaum Y, Canatchik ZI. 2002. Repression of ferritin expression modulates cell responsiveness to H-rasinduced growth. Biochem Soc Trans 30(4):777-80.
51. Keaney Jr JF, Vita JA. 1995. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 38(2): 129-54.
52. Kehrer JP. 2000. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149:43-50.
53. Kirkali Z, Guzelsoy M, Mungan MU, Kirkali G, Yorokoglu K. 1999. Serum ferritin as a clinical marker for renal cell carcinoma: Influence of tumor size and volume. Urol Int 62(1):21-5.
54. Konijn AM, Hershko C. 1977. Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Haematol 37(1): 7-16.
55. Koszyca B, Manavis J, Cornish RJ, Blumbergs PC. 2002. Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury. J Clin Neurosci 9(3):298-301.
56. Kubes P, Ward PA. 2000. Leukocyte recruitment and the acute inflammatory response. Brain Pathol 10(1):127-35.
57. Li W, Xu L-H, Yuan X-M. 2004. Macrophage haemoglobin scavenger receptor and ferritin accumulation in human atherosclerotic lesions. Ann NY Acad Sci 1030:196-201.
58. Lin F, Girotti AW. 1997. Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukaemia cells. Arch Biochem Biophys 346(1):131-41.
59. Lipschitz DA, Simon MO, Lynch SR, Dugard J, Bothwell TH, Charlton RW. 1971. Some factors affecting the release of iron from reticuloendothelial cells. Br J Haematol 21:289-303.
60. Liu H, Pope RM. 2004. Phagocytes: Mechanisms of inflammation and tissue destruction. Rheum Dis Clin North Am 30(1): 19-39.
61. Loncar R, Flesche CW, Deussen A. 2004. Myocardial ferritin content is closely related to the degree of ischaemia. Acta Physiol Scand 180:21-8.
62. Marziali G, Perrotti E, Ilari R, Testa U, Coccia EM, Battis tini A. 1997. Transcriptional regulation of the ferritin heavy-chain gene: The activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol 17(3):1387-95.
63. Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Descamps-Latscha B, Drucke TB, Jungers P. 2001. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kid Int Suppl 78:8243-5.
64. Maxim PE, Veltri RW. 1986. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck. Cancer 57(2):305-11.
65. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. 1991. Ironindependent induction of ferritin H chain by tumor necrosis factor. Proc Nat Acad Sci USA 88(11):4946-50.
66. Motterlini R, Foresti R, Intaglietta M, Winslow RM. 1996. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270(1 Pt 2):H107-14.
67. Noyes WD, Bothwell TH, Finch CA. 1960. The role of the reticulo-endothelial cell in iron metabolism. Br J Haematol 6:43-55.
68. Oberle S, Polte T, Abate A, Podhaisky HP, Schroder H. 1998. Aspirin increases ferritin synthesis in endothelial cells: A novel antioxidant pathway. Circ Res 82(9):1016-20.
69. Olesen SP. 1987. Free oxygen radicals decrease electrical resistance of microvascular endothelium in brain. Acta Physiol Scand 129(2):181-7.
70. Ono S, Zhang Z-D, Marton LS, Yamini B, Windmeyer E, Johns L, Kowalczuk A, Lin G, Macdonald RL. 2000. Heme oxygenase-1 and ferritin are increased in cerebral arteries after subarachnoid hemorrhage in monkeys. J Cereb Blood Flow & Metab 20:1066-76.
71. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. 2001. Ferritin and the response to oxidative stress. Biochem J 357:241-7.
72. Pang J-HS, Jiang M-J, Chen Y-L, Wang F-W, Wang DL, Chu S-H, Chau L-Y. 1996. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97(10):2204-12.
73. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C. 2004. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119:529-42.
74. Picard V, Epsztejn S, Sanrambrogio P, Cabantchik ZI, Beaumont C. 1998. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem 273(25):15382-6.
75. Piñero DJ, Hu J, Cook BM, Scaduto Jr, RC, Connor JR. 2000. Interleukin-1β increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim Biophys Acta 1497:279-88.
76. Powell LW, Alpert E, Isselbacher KJ, Drysdale JW. 1975. Human isoferritins: Organ specific iron and apoferritin distribution. Br J Haematol 30:47-132.
77. Rankin JA. 2004. Biological mediators of acute inflammation. AACN Clin Iss 15(1):3-17.
78. Regan RF, Kumar N, Gao F, Guo Y. 2002. Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience 113(4):985-94.
79. Reif DW. 1992. Ferritin as a source of iron for oxidative damage. Free Rad Biol Med 12:417-27.
80. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. 1990. Translational control during the acute phase response; ferritin synthesis in response to interleukin-1. J Biol Chem 265(24): 14572-8.
81. Rogers J, Lacroix L, Durmowitz G, Kasschau K, Andriotakis J, Bridges KR. 1994. The role of cytokines in the regulation of ferritin expression. Adv Exp Med Biol 356:127-32.
82. Rogers JT. 1996. Ferritin translation by interleukin-1 and interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87(6):2525-37.
83. Rowley D, Gutteridge JM, Blake D, Farr M, Halliwell B. 1984. Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 66(6):691-5.
84. Sanyal B, Polak PE, Szuchet S. 1996. Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes. J Neurosci Res 46(2):187-97.
85. Savarino A, Pescarmona GP, Boelaert JR. 1999. Iron metabolism and HIV infection: Reciprocal interactions with potentially harmful consequences. Cell Biochem Funct 17:279-87.
86. Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump DC. 1992. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen free radicals. J Biol Chem 267(1):597-601.
87. Shterman N, Kupfer B, Moroz C. 1991. Comparison of transferrin receptors, iron content and isoferritn profile in normal and malignant human breast cell lines. Pathobiol 59(1):19-25.
88. Silber JH, Evans AE, Fridman M. 1991. Models to predict outcome from childhood neuroblastoma: The role of serum ferritin and tumor histology. Cancer Res 51(5):1426-33.
89. Speyer BE, Fielding J. 1979. Ferritin as a cytosol iron transport intermediate in human reticulocytes. Br J Haematol 42:255-67.
90. Stites SW, Plautz MW, Bailey K, O'Brien-Ladner AR, Wesselius LJ. 1999. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am J Respir Crit Care Med 160(3):796-801.
91. Torrance JD, Charlton RW, Simon MO, Lynch SR, Bothwell TH. 1978. The mechanism of endotoxin-induced hypoferremia. Scand J Haematol 21:403-10.
92. Torti SV, Torti FM. 1994. Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10:119-37.
93. Torti FM, Torti SV. 2002. Regulation of ferritin genes and protein. Blood 99(10):3505-16.
94. Tribe RM, Poston L. 1996. Oxidative stress and lipids in diabetes: A role in endothelium vasodilator dysfunction? Vase Med 1(3): 195-206.
95. Tripathi PK, Chatterjee SK. 1996. Elevated expression of ferritin H-chain mRNA in metastatic ovarian tumor. Can Invest 14(6):518-26.
96. Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, Torti FM. 2000. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20(16):5818-27.
97. Vanlandingham JW, Levenson CW. 2003. Effect of retinoic acid on ferritin H expression during brain development and neuronal differentiation. Nutr Neurosci 6(1):39-45.
98. Vernet M, Renversez JC, Lasne Y, Revenant MC, Charlier de Bressing C, Guillemin C, Pressac M, Rymer JC. 1995. Comparison of six serum ferritin immunoassays and isoferritin immunoassays and isoferritin spectrotypes in malignancies. Ann Biol Clin 53:419-27.
99. Vet JA, van Moorselaar RJ, Debruyne FM, Schalken JA. 1997. Differential expression of ferritin heavy chain in a rat transitional cell carcinoma progression model. Biochim Biophys Acta 1360(1):39-44.
100. Wagstaff M, Worwood M, Jacobs A. 1982. Iron and isoferritins in iron overload. Clin Sci 62(5):529-40.
101. Whittaker D, Torrance JD, Kew MC. 1984. Isolation of ferritin from human hepatocellular carcinoma. Scand J Haematol 33(5):432-9.
102. Worwood M. 1982. Ferritin in human tissues and serum. Clin Haematol 11(2):275-307.
103. Worwood M. 1990. Ferritin. Blood Rev 4:259-69.
104. Wu KJ, Polack A, Dalla-Favera R. 1999. Coordinated regulation of iron-controlling genes, H-ferritin and IRP-2, by c-MYC. Sci 283(5402):676-9.
105. Yang DC, Wang F, Elliott RL, Head JF. 2001. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res 21(1B):541-9.
106. You SY, Zhang CY, Yi XP, Huang W. 2001. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin. Hybridoma 20(4):243-8.
107. Yuan X-M, Li W, Baird SK, Carlsson M, Melefors Ö. 2004. Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Rad Research 38(10):1133-42.